The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
The global Amifostine market was valued at US$ 50 million in 2023 and is anticipated to reach US$ 58 million by 2030, witnessing a CAGR of 2.1% during the forecast period 2024-2030.
Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.
This report aims to provide a comprehensive presentation of the global market for Amifostine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amifostine.
Report Scope
The Amifostine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amifostine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amifostine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Segment by Type
400mg/Dose
500mg/Dose
Segment by Application
Head and Neck Cancer Adjuvant Therapy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amifostine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amifostine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
The global Amifostine market was valued at US$ 50 million in 2023 and is anticipated to reach US$ 58 million by 2030, witnessing a CAGR of 2.1% during the forecast period 2024-2030.
Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.
This report aims to provide a comprehensive presentation of the global market for Amifostine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amifostine.
Report Scope
The Amifostine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amifostine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amifostine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Segment by Type
400mg/Dose
500mg/Dose
Segment by Application
Head and Neck Cancer Adjuvant Therapy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amifostine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amifostine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Amifostine Market Overview
1.1 Product Overview and Scope of Amifostine
1.2 Amifostine Segment by Type
1.2.1 Global Amifostine Market Value Comparison by Type (2024-2030)
1.2.2 400mg/Dose
1.2.3 500mg/Dose
1.3 Amifostine Segment by Application
1.3.1 Global Amifostine Market Value by Application: (2024-2030)
1.3.2 Head and Neck Cancer Adjuvant Therapy
1.3.3 Others
1.4 Global Amifostine Market Size Estimates and Forecasts
1.4.1 Global Amifostine Revenue 2019-2030
1.4.2 Global Amifostine Sales 2019-2030
1.4.3 Global Amifostine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amifostine Market Competition by Manufacturers
2.1 Global Amifostine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amifostine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amifostine Average Price by Manufacturers (2019-2024)
2.4 Global Amifostine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amifostine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amifostine, Product Type & Application
2.7 Amifostine Market Competitive Situation and Trends
2.7.1 Amifostine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amifostine Players Market Share by Revenue
2.7.3 Global Amifostine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amifostine Retrospective Market Scenario by Region
3.1 Global Amifostine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amifostine Global Amifostine Sales by Region: 2019-2030
3.2.1 Global Amifostine Sales by Region: 2019-2024
3.2.2 Global Amifostine Sales by Region: 2025-2030
3.3 Global Amifostine Global Amifostine Revenue by Region: 2019-2030
3.3.1 Global Amifostine Revenue by Region: 2019-2024
3.3.2 Global Amifostine Revenue by Region: 2025-2030
3.4 North America Amifostine Market Facts & Figures by Country
3.4.1 North America Amifostine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amifostine Sales by Country (2019-2030)
3.4.3 North America Amifostine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amifostine Market Facts & Figures by Country
3.5.1 Europe Amifostine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amifostine Sales by Country (2019-2030)
3.5.3 Europe Amifostine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amifostine Market Facts & Figures by Country
3.6.1 Asia Pacific Amifostine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amifostine Sales by Country (2019-2030)
3.6.3 Asia Pacific Amifostine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amifostine Market Facts & Figures by Country
3.7.1 Latin America Amifostine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amifostine Sales by Country (2019-2030)
3.7.3 Latin America Amifostine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amifostine Market Facts & Figures by Country
3.8.1 Middle East and Africa Amifostine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amifostine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amifostine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Amifostine Sales by Type (2019-2030)
4.1.1 Global Amifostine Sales by Type (2019-2024)
4.1.2 Global Amifostine Sales by Type (2025-2030)
4.1.3 Global Amifostine Sales Market Share by Type (2019-2030)
4.2 Global Amifostine Revenue by Type (2019-2030)
4.2.1 Global Amifostine Revenue by Type (2019-2024)
4.2.2 Global Amifostine Revenue by Type (2025-2030)
4.2.3 Global Amifostine Revenue Market Share by Type (2019-2030)
4.3 Global Amifostine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amifostine Sales by Application (2019-2030)
5.1.1 Global Amifostine Sales by Application (2019-2024)
5.1.2 Global Amifostine Sales by Application (2025-2030)
5.1.3 Global Amifostine Sales Market Share by Application (2019-2030)
5.2 Global Amifostine Revenue by Application (2019-2030)
5.2.1 Global Amifostine Revenue by Application (2019-2024)
5.2.2 Global Amifostine Revenue by Application (2025-2030)
5.2.3 Global Amifostine Revenue Market Share by Application (2019-2030)
5.3 Global Amifostine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Clinigen
6.1.1 Clinigen Corporation Information
6.1.2 Clinigen Description and Business Overview
6.1.3 Clinigen Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Clinigen Amifostine Product Portfolio
6.1.5 Clinigen Recent Developments/Updates
6.2 Sun Pharmaceutical
6.2.1 Sun Pharmaceutical Corporation Information
6.2.2 Sun Pharmaceutical Description and Business Overview
6.2.3 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sun Pharmaceutical Amifostine Product Portfolio
6.2.5 Sun Pharmaceutical Recent Developments/Updates
6.3 Taj Pharmaceuticals
6.3.1 Taj Pharmaceuticals Corporation Information
6.3.2 Taj Pharmaceuticals Description and Business Overview
6.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Taj Pharmaceuticals Amifostine Product Portfolio
6.3.5 Taj Pharmaceuticals Recent Developments/Updates
6.4 Merro Pharmaceutical
6.4.1 Merro Pharmaceutical Corporation Information
6.4.2 Merro Pharmaceutical Description and Business Overview
6.4.3 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merro Pharmaceutical Amifostine Product Portfolio
6.4.5 Merro Pharmaceutical Recent Developments/Updates
6.5 Luye Pharma
6.5.1 Luye Pharma Corporation Information
6.5.2 Luye Pharma Description and Business Overview
6.5.3 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Luye Pharma Amifostine Product Portfolio
6.5.5 Luye Pharma Recent Developments/Updates
6.6 Mingren Pharma
6.6.1 Mingren Pharma Corporation Information
6.6.2 Mingren Pharma Description and Business Overview
6.6.3 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mingren Pharma Amifostine Product Portfolio
6.6.5 Mingren Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amifostine Industry Chain Analysis
7.2 Amifostine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amifostine Production Mode & Process
7.4 Amifostine Sales and Marketing
7.4.1 Amifostine Sales Channels
7.4.2 Amifostine Distributors
7.5 Amifostine Customers
8 Amifostine Market Dynamics
8.1 Amifostine Industry Trends
8.2 Amifostine Market Drivers
8.3 Amifostine Market Challenges
8.4 Amifostine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
